Negotiating the relationship between addiction, ethics, and brain science

AJOB Neuroscience

Volumn 1, Issue 1, 2010, Pages 36-45

  Buchman, Daniel Z ^a   Skinner, Wayne ^b,c   Illes, Judy ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Mental health; Neuroethics; Public health; Sociology

Indexed keywords

EID: 79952984220     PISSN: 21507740     EISSN: 21507759     Source Type: Journal    
DOI: 10.1080/21507740903508609     Document Type: Article

References (103)

1. American Psychiatric Association. 2004. Diagnostic and statistical manual of mental disorders, DSM-IV-TR, fourth edition text revision. Washington, DC: American Psychiatric Association.
2. Andreou C. 2008. Making a clean break: Addiction and Ulysses contracts. Bioethics 22: 25-31.
3. Anstice, S., C. J. Strike, and B. Brands. 2009. Supervised methadone consumption: Client issues and stigma. Substance Use and Misuse 44(6): 794-808.
4. Aristotle. 1999. Nicomachean ethics, trans. T. Irwin, 2nd ed. Indianapolis, IN: Hackett.
5. Ashcroft, R., A. V. Campbell, and B. Capps. 2007. Ethical aspects of developments in neuroscience and drug addiction. In Drugs and the future, ed. D. Nutt, T.W. Robbins, G. V. Stimson, M. Ince, and A. Jackson, 439-465. London: Elsevier.
6. Babor, T., R. Caetano, S. Casswell, G. Edwards, N. Giesbrecht, and K. Graham. 2003. Alcohol: No ordinary commodity: Research and public policy. New York: Oxford University Press.
7. BBC. 2007. Brain's 'addiction centre' found. Thursday, 25 January. Available at http://news.bbc.co.uk/2/hi/health/6298557.stm
8. Bechara, A., and H. Damasio. 2002. Decision-making and addiction (part 1): Impaired activation of the somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 40: 1675-1689.
9. Buchman, D. Z., and B. J. Russell. 2009. Addictions, autonomy and so much more: A reply to Caplan. Addiction 104: 1053-1055.
10. Bunge, M. 1979. Treatise on basic philosophy, Vol. 4: A world of systems. Dordrecht, the Netherlands: Kluwer.
11. Bunge, M. 1991. The power and limits of reduction. In The problem of reductionism in science, ed. E. Agazzi, 31-49. Dordrecht the Netherlands: Kluwer Academic.
12. Bunge, M. 1997. Mechanism and explanation. Philosophy of the Social Sciences 27: 410-465.
13. Bunge, M. 2003. Emergence and convergence. Toronto: University of Toronto Press.
14. Bunge, M. 2004. How does it work? The search for explanatory mechanisms. Philosophy of the Social Sciences 34: 182-210.
15. Burns, K., and A. Bechara. 2007. Decision making and free will: A neuroscienceperspective. Behavioral Science and the Law 25: 263-280.
16. Caetano, R., and C. Clark. 1998. Trends in alcohol consumption patterns among Whites, Blacks and Hispanics: 1984 and 1995. Journal of Studies on Alcohol 59: 659-668.
17. Caplan, A. L. 2006. Ethical issues surrounding forced, mandated or coerced treatment. Journal of Substance Abuse Treatment. 31: 117-120.
18. Caplan, A. L. 2008. Denying autonomy in order to create it: The paradox of forcing treatment upon addicts. Addiction, 103: 1919-1921.
19. Carter, A., and W. Hall. 2008a. Informed consent to opioid agonist maintenance treatment: Recommended ethical guidelines. International Journal of Drug Policy 19(1): 79-89.
20. Carter, A., and W. Hall. 2008b. The issue of consent in research that administers drugs of addiction to addicted persons. Accountability in Research 15(4): 209-225.
21. Charland, L. C. 2002. Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics 2(2): 37-47.
22. Charland, L. C. 2003. Heroin addicts and consent to heroin therapy: A comment on Hall et al. Addiction 98(11): 1634-1635.
23. Childress, A. R., Mozely, P. D., McElgin, W., Fitzgerald, J., Reivich, M., and O'Brian, C. P. 1999. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156: 11-18.
24. Christie, M. J. 2008. Cellular neuroadaptations to chronic opioids: Tolerance, withdrawal and addiction. British Journal of Pharmacology 154(2): 384-396.
25. Christman J. 2004. Relational autonomy, liberal individualism, and the social constitution of selves. Philosophical Studies 117: 143-164.
26. Cochrane, T. I. 2007. Brain disease or moral condition?Wrong question. American Journal of Bioethics 7(1): 24-25.
27. Dackis, C., and C. O'Brien. 2005. Neurobiology of addiction: Treatment and public policy ramifications. Nature Neuroscience 8(11): 1431-1436.
28. Damasio, A. R. 1994. Descartes' error. New York: Harper Collins.
29. Dehue, T. 2002. A Dutch treat: Randomized controlled experimentation and the case of heroin-maintenance in the Netherlands. History of the Human Sciences 15(2): 75-98.
30. Des Jarlais, D. C., A. Kamyar, and H. Hagan. 2008. Evaluating Vancouver's supervised injection facility: Data and dollars, symbols and ethics. Canadian Medical Association Journal 179(11): 1105-1106.
31. Dietrich, S., H. Matschinger, and M. C. Angermeyer. 2006. The relationship between biogenetic causal explanations and social distance toward people with mental disorders: Results from a population survey in Germany. International Journal of Social Psychiatry 52(2): 166-174.
32. Dom, G., B. Sabbe, W. Hulstijn, and W. Van Den Brink. 2005. Substance use disorders and the orbitofrontal cortex. British Journal of Psychiatry 187: 209-220.
33. Dumit, J. 2003. Is it me or my brain? Depression and neuroscientific facts. Journal of Medical Humanities 24(1-2): 35-47.
34. Elliott, R., J. Csete, E. Wood, and T. Kerr. 2005. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy. Health and Human Rights 8: 104-138.
35. Elster, J., and O.-J. Skog. 1999. Getting hooked: Rationality and addiction. Cambridge, UK: Cambridge University Press.
36. Engel, G. L. 1977. The need for a new medical model: A challenge for biomedicine. Science, 196: 129-136.
37. Fischer, B., J. Rehm, S. Brissette, et al. 2005. Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health 82(2): 250-266.
38. Fischer, B., E. Oviedo-Joekes, P. Blanken, C. Haasen, J. Rehm, M. T. Schechter, J. Strang, and W. van den Brink. 2007. Heroin-assisted treatment (HAT) a decade later: A brief update on science and politics. Journal of Urban Health 84(4): 552-562.
39. Foddy, B., and J. Savulescu. 2006. Addiction and autonomy: Can addicted people consent to the prescription of their drug of addiction? Bioethics 20: 1-15.
40. Foddy, B., and J. Savulescu. 2007. Addiction is not an affliction: Addictive desires are merely pleasure-oriented desires. American Journal of Bioethics 7: 29-32.
41. Frank, A. 2004. Ethics as process and practice. Internal Medicine Journal 34: 355-357.
42. Fry, C. L. 2008. A social neuroethics of addiction: Revealing public and private identities and self understanding. Poster at the 1st Annual Meeting of the Neuroethics Society, Washington, DC.
43. Gaylin, W., and B. Jennings. 2003. The perversion of autonomy: Coercion and constraints in a liberal society. Washington, DC: Georgetown University Press.
44. Gillett, G. 2008a. Autonomy and selfishness. Lancet 372(9645): 1214-1215.
45. Gillett, G. 2008b. Subjectivity and being somebody: Human identity and neuroethics. Exeter: Imprit Academics.
46. Gillett, G. 2009. Intention, autonomy, and brain events. Bioethics 23(6): 330-339.
47. Godin, G., and G. Kok. 1996. The theory of planned behavior: A review of its applications to health-related behaviors. American Journal of Health Promotion 11: 87-98.
48. Haasen, C., U. Verthein, P. Degkwitz, J. Berger, M. Krausz, and D. Naber. 2007. Heroin-assisted treatment for opioid dependence. British Journal of Psychiatry 191: 55-62.
49. Hall, W., B. Capps, and A. Carter. 2008. The use of depot naltrexone under legal coercion: The case for caution. Addiction 103: 1922-1924.
50. Hall, W., L. Carter, and K. I. Morely. 2003a. Addiction, neuroscience and ethics. Addiction 98(7): 867-870.
51. Hall, W., L. Carter, and K. I. Morely. 2003b. Addiction, ethics and scientific freedom. Addiction 103: 873-874.
52. Hawkins, J. D., R. F. Catalano, and J. Y. Miller. 1992. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin 112: 64-105.
53. Health Canada. 2007. Canadian tobacco use monitoring survey. August 25. Available at http://www.hc-sc.gc.ca/hl-vs/tobactabac/researchrecherche/stat/ctums-esutc2007-eng.php
54. Heylighen, F., P. Cilliers, and C. Gerschenson, C. 2007. Philosophy and complexity. In Complexity, science and society, ed. J. Bogg and R. Geyer, 117-134. Radcliffe: Oxford University Press.
55. Hunt, N. 2004. Public health or human rights: What comes first? International Journal of Drug Policy 15(4): 231-237.
56. Hyman, S. E. 2005. Addiction: A disease of learning and memory. American Journal of Psychiatry 162(8): 1414-1422.
57. Hyman, S. E. 2007. The neurobiology of addiction: Implications for voluntary control of behavior. American Journal of Bioethics 7(1): 8-11.
58. Julien, R. M. 2001. A primer of drug action, 9th ed. New York: Worth.
59. Kaufman, J., T. Ross, E. Stein, and H. Garavan. 2003. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience 23: 7839-7843.
60. Killias, M., M. Aebi, and D. Ribeaud. 1998. Effects of heroin prescription on police contacts among drug-addicts. European Journal on Criminal Policy and Research 6(3): 433-438.
61. Koob, G. F., and M. Le Moal. 2005. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience 8: 1442-1444.
62. Koob, G. F., P. P. Sanna, and F. E. Bloom. 1998. Neuroscience of addiction. Neuron 21(3): 467-476.
63. Lasnier, B., Brochu, S., Boyd, N., and Fischer, B. 2010. A heroin prescription trial: Case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods. International Journal of Drug Policy, 21(1): 28-35.
64. Lauer, R. H., and J. C. Lauer. 2002. Social problems and the quality of life, 8th ed. New York: McGraw-Hill.
65. Leshner, A. I. 1997. Addiction is a brain disease, and it matters. Science 278: 45-57.
66. Levy, N. 2006. Autonomy and addiction. Canadian Journal of Philosophy 36(3): 427-448.
67. Levy, N. 2007a. Neuroethics: Challenges for the 21st century. New York: Cambridge University Press.
68. Levy, N. 2007b. The social: A missing term in the debate over addiction and voluntary control. American Journal of Bioethics 7: 35-36.
69. Li, C. S., and R. Sinha. 2008. Inhibitory control and emotional stress regulation: Neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neuroscience and Biobehavioral Reviews 32: 581-597.
70. Lines, R., and R. Elliott. 2007. Injecting drugs into human rights advocacy. International Journal of Drug Policy 18: 453-457.
71. Mehta, S., and A. Farina. 1997. Is being sick really better? Effect of the disease view of mental disorder on stigma. Journal of Social and Clinical Psychology 16(4): 405-419.
72. Merton, R. K. 1961. Social problems and sociological theory. In Contemporary social problems, ed. R. K. Merton and R. A. Nisbet, 697-737. New York: Harcourt.
73. Miller, W. R., and K. M. Carroll. 2006. Drawing the science together: Ten principles, ten recommendations. In Rethinking substance abuse: What the science shows, and what we should do about it, ed.W. R. Miller and K. M. Carroll, 293-311. New York: Guilford Press.
74. Morse, S. J. 2007. Voluntary control of behavior and responsibility. American Journal of Bioethics 7(1): 12-36.
75. Oviedo-Joekes, E., B. Nosyk, S. Brissette, et al. 2008. The North American Opiate Medication Initiative (NAOMI): Profile of participants in North America's first trial of heroin-assisted treatment. Journal of Urban Health 85(6): 812-825.
76. Oviedo-Joekes, E., B. Nosyk, D. C. Marsh, et al. 2009. Scientific and political challenges in North America's first randomized controlled trial of heroin assisted treatment for severe heroin addiction: Rationale and design of the NAOMI study. Clinical Trials 6(3): 261-271.
77. Phelan, J., L. Yang, L., and R. Cruz-Rojas. 2006. Effects of attributing serious mental illnesses to genetic causes on orientations to treatment. Psychiatric Services 57: 382-387.
78. Racine, E., O. Bar-Ilan, and J. Illes. 2005. fMRI in the public eye. Nature Reviews Neuroscience 6(2): 159-164.
79. Raphael, D. 2004. Introduction to the social determinants of health. In Social determinants of health: Canadian perspectives, ed.D. Raphael, 1-18. Toronto: Canadian Scholars' Press.
80. Read, J. 2007. Why promoting biological ideology increases prejudice against people labelled "schizophrenic. " Australian Psychologist 42(2): 118-128.
81. Read, J., N. Haslam, L. Sayce, and E. Davies. 2006. Prejudice and schizophrenia: A review of the 'mental illness is an illness like any other' approach. Acta Psychiatrica Scandinavica, 114: 303-318.
82. Rehm, J., and B. Fischer. 2008. Should heroin be prescribed to heroin misusers? Yes. British Medical Journal 336(7635): 70.
83. Reinarman, C., P. D. Cohen, and H. L. Kaal. 2004. The limited relevance of drug policy: Cannabis in Amsterdam and in San Francisco. American Journal of Public Health 94: 836-842.
84. Rush, B., K. Urbanoski, D. Bassani, D., et al. 2008. Prevalence of cooccurring substance use and other mental disorders in the Canadian population. Canadian Journal of Psychiatry 53(12): 800-809.
85. Russell, B. 2009. Patient autonomy writ large. American Journal of Bioethics 9(2): 32-34.
86. Satel, S. K. 1999. What should we expect from drug abusers? Psychiatric Services 50: 861.
87. Searle, J. R. 2004. Freedom and neurobiology. New York: Columbia University Press.
88. Sherwin, S. 1998. A relational approach to autonomy in health care. In The politics of women's health: Exploring agency and autonomy, ed. S. Sherwin, 19-47. Philadelphia: Temple University Press.
89. Shiloh, S., D. Rashuk-Rosenthal, and Y. Benyamini. 2002. Illness causal attributions. An exploratory study of their structure and associations with other illness cognitions and perceptions of control. Journal of Behavioral Medicine 25: 373-394.
90. Sinha, R., and C.-S. R. Li. 2007. Imaging stress-and cue-induced drug and alcohol craving: Association with relapse and clinical implications. Drug and Alcohol Review 26: 25-31.
91. Soon, C. S., M. Brass, M., H.-J. Heinze, and J.-D. Haynes. 2008. Unconscious determinants of free decisions in the human brain. Nature Neuroscience 11(5): 543-545.
92. Strike, C. J., T. Myers, and M. Millson. 2004. Finding a place for needle exchange programs. Critical Public Health 14(3): 261-275.
93. Taylor, C. 1989. Sources of the self: The making of modern identity. Cambridge, MA: Harvard University Press.
94. Thomas, Y. F. 2007. The social epidemiology of drug abuse. American Journal of Preventive Medicine 32(6S): S141-S146.
95. Uhl, G., T. Drgon, C. Johnson, and Q.-R. Liu. 2009. Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. Journal of Neurogenetics 23(3): 272-282.
96. Verdejo-Garcia, A., and A. Bechara. 2009. A somatic marker theory of addiction. Neuropharmacology 56: 48-62.
97. Volkow, N., and T.-K. Li. 2005. The neuroscience of addiction. Nature Neuroscience 8: 1429-1430.
98. Volkow, N. D., J. S. Fowler, G. J. Wang, R. Baler, and F. Telang. 2009. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56: 3-8.
99. Wallace, J. J. 1999. The social ecology of addiction: Race, risk and resilience. Pediatrics 103: 1122-1127.
100. Wallace, J. J., J. Bachman, P. O'Malley, L. Johnston, J. Schulenberg, and S. Cooper. 2002. Tobacco, alcohol, and illict drug use: Racial and ethnic differences among U.S. high school seniors, 1976-2000. Public Health Reports, 117(suppl. 1): S67-S75.
101. Weiss, F. 2005. Neurobiology of craving, conditioned reward and relapse. Current Opinion in Pharmacology 5: 9-19.
102. Wegner, D. 2002. The illusion of conscious will. Cambridge, MA: MIT Press.
103. Xu, Z., B. Hou, Y. Gao, F. He, and C. Zhang. 2007. Effects of enriched environment on morphine-induced reward in mice. Experimental Neurology 204(2): 714-719.